Study of immune status dynamics in rats with induced benign prostatic hyperplasia
DOI:
https://doi.org/10.12775/JEHS.2024.58.019Keywords
benign prostatic hyperplasia, cytokines, pathogenesisAbstract
The article presents the results of a study on pro- and anti-inflammatory cytokines in rats with experimentally induced benign prostatic hyperplasia. It was found that the levels of tumor necrosis factor-α, interleukin-8, and interleukin-6 – pro-inflammatory cytokines – increased sharply, while the levels of anti-inflammatory cytokines, on the contrary, decreased. In addition, there was a significant increase in tissue growth factor-β, which may indicate progressive fibrotic proliferation in the prostate gland. The obtained data on the dynamics of plasma and prostatic levels of cytokines interleukin-8 and interleukin-10 suggest that despite changes in their concentrations, the most pronounced imbalance occurs at the organ level (in prostate homogenate). This is characterized by excessive secretion of the pro-inflammatory cytokine interleukin-8 against the background of a relative deficiency of the anti-inflammatory cytokine interleukin-10, which supports the hypothesis about the important role of cytokine imbalance in the activation and persistence of chronic aseptic inflammation in the prostate.
References
1. Lloyd G. L., Marks J. M., Ricke W. A. Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation? Current urology reports. 2019. Vol. 20 (9). P. 54.
2. Phua T. J. The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective. Medicines (Basel, Switzerland). 2021. Vol. 8(6). P. 30.
3. Madersbacher S., Sampson N., Culig Z. Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review. Gerontology. 2019. Vol. 65(5). P. 458–464.
4. Multidisciplinary approach to prostatitis / V. Magri, M. Boltri, T. Cai et al. Archivio italiano di urologia, andrologia. 2019. Vol. 90 (4). P. 227–248.
5. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis / B. Malling, M. A. Røder, K. Brasso et al. European radiology. 2015. Vol. 29 (1). P. 287–298.
6. Reznikov O. G., Solovyov A. I., Stefanov O. V. Biotic examination of preclinical and other scientific studies performed on animals: method. recommendations Herald of pharmacology and pharmacy. 2006. No. 7. P. 47–61.
7. Clinical laboratory diagnostics: a study guide / B. D. Lutsik, L. E. Lapovets, G. B. Lebed, etc.; under the editorship B. D. Lutsyk. – 2nd edition. K.: Medicine, 2018. 288 p.
8. Chronic inflammation promotes proliferation in the prostatic stroma in rats with experimental autoimmune prostatitis: study for a novel method of inducing benign prostatic hyperplasia in a rat model / M. Zhang, C. Luo, K. Cui et al. World journal of urology. 2020. Vol. 38 (11). P. 2933–2943.
9. Tsunemori H., Sugimoto M. Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: a literature review. International journal of urology: official journal of the Japanese Urological Association. 2021. Vol. 28 (11). P. 1086–1092.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 S. Lul’ko, I. Savytskyi, M. Ostapets

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 1
Number of citations: 0